Venture Capital Deals and Investments
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Venture Capital Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
Indomo Secures $25M Funding Round Led by Atomic, Foresite Capital, and Polaris Partners
Growth StageVenture Capital

Indomo Secures $25M Funding Round Led by Atomic, Foresite Capital, and Polaris Partners

•November 3, 2025
•Nov 3, 2025
0

Participants

InDomo

InDomo

company

Foresite Capital

Foresite Capital

investor

Polaris Partners

Polaris Partners

investor

Atomic

Atomic

investor

Why It Matters

The funding accelerates Indomo’s path to market, potentially expanding the at‑home prescription dermatology segment and challenging traditional in‑office skin‑care models. It also signals strong venture confidence in combining pharmaceuticals with innovative delivery technologies in the broader digital‑health landscape.

Deal Summary

Boston‑based therapeutics firm Indomo announced a $25 million financing to advance its Phase 2 trials and device platform. The round was backed by Atomic, Foresite Capital, Polaris Partners and other investors. Funds will support the development of its at‑home acne treatment ClearPen.

0

Comments

Want to join the conversation?

Loading comments...